NEORX CORP
S-8, EX-23.1, 2000-07-19
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEORX CORP, S-8, EX-5.1, 2000-07-19
Next: NEORX CORP, S-8, EX-99.1, 2000-07-19



<PAGE>   1
                                                                    EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
NeoRx Corporation:

We consent to the use of our report incorporated herein by reference.

/S/ KPMG LLP
Seattle, Washington
July 14, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission